The Dow Jones Industrial Average and other major index futures traded higher, as a critical inflation report produced no surprises for investors Friday. Meanwhile, Apple, Atlassian and Deckers Outdoor were big earnings movers on the stock market today,

Stock futures are higher Friday morning as investors respond to a steady stream of earnings reports and await the release of a closely followed inflation indicator.

Dow said on Thursday it will lay off 1,500 employees as part of its $1 billion cost savings plan due to lackluster demand and margin pressures, causing its shares to drop 6.3% in morning trade.

Stock futures are mixed Thursday morning as investors react to a barrage of earnings reports from major companies and important economic indicators.

P&G is a unique Dividend King because it uses both buybacks and dividends to return capital to shareholders. A Dividend King like Coca-Cola may yield more than P&G, but it doesn't consistently buy back stock.

Midland-based Dow is eliminating 1,500 jobs around the world as part of a plan to cut $1 billion worth of spending.

SP500 gains ground despite the weaker-than-expected GDP Growth Rate report. The report showed that GDP Growth Rate declined from 3.1% to 2.3%, compared to analyst consensus of 2.6%. Initial Jobless Claims report showed that 207,

Eight of the 30 Dow components lost value in 2024. Here's a quick look at each company, to help you determine which dividend stocks stand out as the best buys right now.

S&P 500 futures rise as Meta and Tesla gain, but Microsoft and Caterpillar drag the Dow. US stock market reacts to earnings, GDP data, and Fed outlook.

The Dow Jones held up best out of major indexes on the stock market today. Nvidia plunged due to concerns of China AI firm DeepSeek.

In addition to Olay, P&G said it is innovating in core brands like Pantene and Head and Shoulders, and saw 5% growth in P&G-owned Japanese luxury skincare brand, SK II. P&G attributed the strong performance of SK II to brand building and improved sentiment in China toward Japanese brands.

Good news about an experimental weight-loss shot sent shares in Ozempic maker Novo Nordisk soaring, making it once again Europe's most-valuable listed company. A pullback in the Danish drug maker's shares had meant it recently ceded that title to French luxury conglomerate LVMH.